Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its ...

At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the "Most Promising ADC Clinical Candidate in Taiwan" award. This recognition follows OBI Pharma’s ...

CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western studyFast Track Designation granted by FDA for CRB-701 to ...

Less than a month after unveiling a peptide expansion at its production site in Mourenx, CDMO Axplora has hit the gas on a ...

Callio Therapeutics has raised $187m in a Series A financing round to achieve clinical proof-of-concept for its human ...

HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased ...

New research from Appian , in partnership with Coforge (NSE: COFORGE), reveals that, on average, process inefficiency costs ...

TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...

Data supplied by Morningstar and accurate on Sep 21, 2023. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

SAN RAFAEL, Calif., Feb. 24, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has appointed Timothy P. Walbert, former chairman, president and ...

Mumbai-based Aveo Pharmaceuticals, however, claimed the combination is approved by the relevant state drug authorities and is exported under necessary approval from the assistant drug controllers with ...

This combination is licenced by the relevant State Food and Drug Administration (FDA) and is exported under the necessary NOC from the Assistant Drug Controllers (ADC ... been using Aveo ...